Format

Send to

Choose Destination
Leukemia. 2014 May;28(5):1167-70. doi: 10.1038/leu.2014.14. Epub 2014 Jan 10.

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

Author information

1
Myeloid Malignancies Section, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
2
Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
3
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
4
1] Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] Cancer Immunology Experimental Medicine, Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland.
5
Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
6
Center for Leukemia and the Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
PMID:
24472813
PMCID:
PMC4013200
DOI:
10.1038/leu.2014.14
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center